genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Search
About GEN
Contact GEN
Subscribe/Update Preferences
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Autoimmune Disease Drugs
Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio
Antibodies
Monoclonal Antibody Prevents Malaria in Clinical Trial
Alzheimers
Novel Alzheimer’s Therapy without Inflammatory Side Effects
News
Muscle Regeneration May Be Boosted by Naturally Occurring Compound
Bacteriophage
Oral Combination Phage Therapy Targets IBD-Related Gut Bacteria, Spares Helpful Microbes
Insights
All
Trends for 2020
Trends for 2021
Alzheimers
Questionable Data Jeopardizes Alzheimer’s Amyloid Theory
Cancer
Left-Field Lessons in Immunity: Z-Nucleic Acids Stage a Comeback
Antibodies
Biomanufacturing Parallels the Semiconductor Chip Revolution
Bioprocessing
Altering Vector Genetics Improves Cell-free Protein Synthesis
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
A-Lists
Seven Biopharma Trends to Watch in 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Home
Antibodies
Bispecific Antibodies
Page 2
Bispecific Antibodies
Antibody Drug Conjugates
Bispecific Antibodies
Epitope Mapping
Monoclonal Antibodies
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Bispecific Antibodies
Innovators Pioneer Cell and Gene Therapy and Multi-Product Companies
Bispecific Antibodies
WuXi Biologics Launches New Drug Product Facility
Bispecific Antibodies
Cytovia Inks Two Deals Covering R&D and Biomanufacturing Operations
Bispecific Antibodies
Lilly, Merus Ink Up-to-$1.6B Bispecific Antibody Partnership vs. Cancer
Bispecific Antibodies
AbCellera’s CEO: Flattening the Curve of Technology Development
Bispecific Antibodies
Alligator, Aptevo Partner on Bispecific Cancer Immunotherapy Targeting 4-1BB
Bispecific Antibodies
F-star, Merck Agree Up to €1B Deal to Develop Five Bispecific...
Bispecific Antibodies
EpimAb Raises $25M in Series A to Progress Bispecific Antibodies into...
Bispecific Antibodies
Hanmi, Innovent Agree to Co-Develop Bispecific Anticancer Antibody
Bispecific Antibodies
Numab, Ono Ink CHF258M Deal for Multispecific Immuno-Oncology Antibody
Bispecific Antibodies
Affimed and MD Anderson Combine NK Cells and Bispecific Abs for...
Bispecific Antibodies
Incyte and Merus Ink $120M Up Front Deal to Develop Multiple...
Bispecific Antibodies
MedImmune, Abpro to Develop Bispecific Antibody
Bispecific Antibodies
Genmab Licenses DuoBody Platform to Gilead for Antibodies Targeting HIV
Bispecific Antibodies
Novartis to Co-Develop Two Xencor Bispecific Antibodies
1
2
3
Page 2 of 3
Scroll Up
